+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relationship between beta-1 adrenergic receptor polymorphisms and the response to beta-blockers in patients with heart failure



Relationship between beta-1 adrenergic receptor polymorphisms and the response to beta-blockers in patients with heart failure



Circulation 104(17 Suppl.): II 661-II 662




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035640599

Download citation: RISBibTeXText


Related references

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenetics and Genomics 15(3): 137-142, 2005

Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovascular Drugs and Therapy 24(1): 49-60, 2010

The beta(2)-adrenergic receptor Arg16-gly polymorphism and interactions involving beta(2)- and beta(3)-adrenergic receptor polymorphisms are associated with variations in longitudinal serum lipid profiles: the Bogalusa Heart Study. Metabolism: Clinical and Experimental 53(9): 1184-1191, 2004

Impact of beta-2 Thr164Ile and combined beta-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients. Brazilian Journal of Medical and Biological Research 43(6): 565-571, 2010

Polymorphisms of the beta-2 adrenergic receptor affect exercise capacity in patients with heart failure. Journal of Investigative Medicine 44(7): 394, 1996

Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure. Bmc Cardiovascular Disorders 9: 50, 2009

Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circulation Research 86(8): 834-840, 2000

Merck cardiovascular research fellowship Effect of beta-adrenergic receptor polymorphisms on the response to metoprolol CR/XL in heart failure. Pharmacotherapy 22(10): 1389, 2002

Beta-adrenergic control of human heart rate variability Prediction by multiple single nucleotide polymorphisms at the beta-2 though not the beta-1 adrenergic receptor genetic loci. American Journal of Hypertension 17(5), 2004

Beta-adrenergic Receptor Blockers in Heart Failure. Current Treatment Options in Cardiovascular Medicine 5(6): 475-485, 2003

Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. American Journal of Cardiology 102(6): 726-732, 2008

Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. New England Journal of Medicine 305(4): 185-190, 1981

Beta1-Adrenergic receptor polymorphisms predict antihypertensive response to beta-blockers. Circulation 106(19 Suppl.): II-574, 2002

Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients. British Journal of Clinical Pharmacology 71(4): 556-565, 2011

Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. American Journal of Medicine 117(7): 451-458, 2004